Hutch News
Results per Page:
Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
For stem cells, no end joining marks the end
From the Kemp Lab, Human Biology Division
Top cancer organizations make recommendations to erase health disparities
Four national organizations push for richer data, more inclusive research to better serve the underserved
IDH1 mutant (or methylation), stops monocyte migration
From the Holland Lab, Human Biology Division
MYCN drives retinoblastoma, but is also bypassed.
From the MacPherson Lab, Human Biology Division
DLG5 the zookeeper: new role in regulating Hippo signaling
From the Vasioukhin Lab (Human Biology Division)
HPV and cancer: Risks for non-HPV16 and HPV18 strains
From the Galloway and Hughes Labs (Human Biology and Vaccine and Infectious Disease Divisions)
Doubling down for cancer cures
Fred Hutch president urges twofold boost in US cancer-research funding
Patients treated at cancer centers live longer: study
Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Good News at Fred Hutch
Dr. Brian Reid invited speaker at NCI Excellence in Molecular Diagnostics lecture series; Dr. Katherine Tarlock earns grant to pursue treatments for childhood cancer
Cancer clinical trials: Separating fact from fiction
A lack of information and understanding is often a barrier to participation
Getting ready to quit smoking? - Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center has the right opportunity for you
Getting back to work
After being shut down for 16 days, the Cancer Information Service is again busy answering calls and emails
Cancer Information Service reopens as government shutdown comes to an end
After nearly three weeks idle, CIS workers once again responding to calls, emails and live-help chat sessions